Protecting Children From Chemical and Surgical Mutilation

This EO states that "it is the policy of the United States that it will not fund, sponsor, promote, assist, or support the so-called “transition” of a child from one sex to another, and it will rigorously enforce all laws that prohibit or limit these destructive and life-altering procedures." The EO directs specific actions at HHS, DoD, and DOJ to enforce this, including stopping insurance support, reviewing policies, and requiring this policy for all federally funded organizations.

• All

Immediate, 60 days, 90 days.

Agencies shall rescind or amend policies relying on WPATH guidance (immediately); Secretary of HHS shall publish a review on existing literature regarding best practices for promoting the health of children with gender dysphoria (90 days); head of each agency shall take steps to ensure institutions with federal funding stop this practice (immediate); Secretary of HHS shall take other appropriate actions to end this practice (immediate); Secretary of Defense shall commence rulemaking to prevent Tricare coverage of this practice for individuals under 18 (immediate); direct FEHB to include this in the 2026 plan (immediate); Attorney General shall review relevant enforcement (immediate); submit a report re; progress (60 days)

Recent Legal and Regulatory Developments Involving Gender-Affirming Care

• PFLAG, INC., et al v. Trump et alSee summary

  D.Md.

  PFLAG, INC., et al v. Trump et al (D.Md.)

• Washington et al v. TrumpSee summary

  W.D.Wa.

  Washington et al v. Trump (W.D.Wa.)

• Commonwealth of Massachusetts v. TrumpSee summary

  D. Mass.

  Commonwealth of Massachusetts v. Trump (D. Mass.)

  View docket →
• Doe v. Department of DefenseSee summary

  D. Md.

  Doe v. Department of Defense (D. Md.)

  View docket →